Maravai LifeSciences
MRVI
MRVI
223 hedge funds and large institutions have $902M invested in Maravai LifeSciences in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 81 increasing their positions, 64 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
33% less capital invested
Capital invested by funds: $1.35B → $902M (-$446M)
50% less call options, than puts
Call options by funds: $1.64M | Put options by funds: $3.28M
Holders
223
Holding in Top 10
3
Calls
$1.64M
Puts
$3.28M
Top Buyers
| 1 | +$33.7M | |
| 2 | +$28.2M | |
| 3 | +$17.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$12.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$11.5M |
Top Sellers
| 1 | -$75.6M | |
| 2 | -$25.5M | |
| 3 | -$21.5M | |
| 4 |
ClearBridge Investments
New York
|
-$15.1M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$14M |